Immunoassays: Technologies and Global Markets

Immunoassays: Technologies and Global Markets

Report Scope:

The report is designed to be a comprehensive business tool to provide an in-depth look at the market for immunoassays. The geographic scope of the report is global. The report reviews each type of immunoassay and reviews technologies associated with immunoassays and equipment. The report also explores market size, identifies market participants and investigates patents in the immunoassays market.

The global market for immunoassays is divided into categories by immunoassay type and by application as follows.

By product:

Enzyme immunoassays.

Fluorescent immunoassays.

Radioimmunoassays.

Chemiluminescent immunoassays.

Lateral flow immunoassays and multiplex immunoassays.

By application:

Diabetes.

Drug screening.

Infectious diseases.

Cancer.

Cardiology.

Reproductive.

Other immunoassays.

Each area is covered in detail, identifying current products in the market in the base year 2021, measuring current market size and identifying current and potential market drivers, forecasting for 2027, assessing current and potential competitors, and identifying current competitor market shares for the base year of 2021.

Report Includes:

124 data tables and 4 additional tables

An up-to-date review and analysis of the global markets for immunoassays and related technologies

Analyses of the global market trends, with historic sales data for 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027

Estimation of the actual market size and revenue forecast for global immunoassays market in USD millions, and corresponding market share analysis based on product type, application, and region

Discussion of the major market dynamics, key shifts and regulations, industry specific challenges, and other region-specific macroeconomic factors affecting the market for immunoassays as a basis for projecting demand over the next few years (2022-2027)

Insight into prevalence of infectious disease, metabolic disorders and chronic ailments; along with the recent breakthrough innovations, clinical trials, and value chain analyses

Assessment of the recent industry structure for microbiome therapeutics, ongoing research (R&D) activities, analysis of the competitive environment, and COVID-19 impact on the biotech industry

Review of the patents and patent applications on immunoassays testing and applications

Competitive landscape of this market featuring leading biopharmaceutical companies, their product portfolios, financial performances, and market share analysis based on recent segmental revenues

Company profiles of major players within the industry, including Abbott Laboratories, Biomerieux S.A., F. Hoffmann-La Roche Ltd., Siemens Healthineers, and Thermo Fisher Scientific

Companies Mentioned

ABBOTT LABORATORIES
ABCAM PLC
BECKMAN COULTER (DANAHER CORP.)
BIO-RAD LABORATORIES INC.
BIOMERIEUX S.A.
DIASORIN
MERCK INC.
MINDRAY
ORASURE TECHNOLOGIES
PERKIN ELMER
QUIDEL CORP.
RANDOX LABORATORIES LTD.
Roche Diagnostics (f. Hoffmann-la Roche Ltd.)
SD BIOSENSOR
SIEMENS HEALTHINEERS
THERMO FISHER SCIENTIFIC INC.